Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This project is a first attempt to assess cough airflow dynamics and true vocal fold (TVF) adduction and abduction angles during voluntary cough to examine the effects of changes in glottal closure due to reduced mobility of one true vocal fold. The hypothesis of this study is that the incomplete glottal closure due to reduced vocal fold mobility will result in changes in true vocal fold adductory and abductory angles during cough and will result in changes to voluntary cough airflow parameters. This study results will contribute to the existing knowledge of the laryngeal contribution to cough airflow dynamics.
The study investigators will consecutively recruit 30 adults diagnosed with vocal fold insufficiency due to reduced mobility of one true vocal fold.
A questionnaire will be used to collect participants' information. Demographic information such as age, gender, race/ethnicity, height, weight, and a major complaint (dysphonia and/or dysphagia) and medical history information determining the eligibility for participation will be collected from the participant. Participant's medical and surgical history specifically related to the diagnosis and the etiology of reduced vocal fold mobility will be obtained from the participant's medical record.
Videolaryngoscopy will be performed as part of standard clinical care. Vocal fold image and cough airflow will be recorded simultaneously during voluntary cough production with the flexible endoscope in nasopharynx. A second part of the study will include spirometry and expiratory muscle strength assessments. Video images of the vocal fold movement during vowel phonation and cough production will be recorded and stored on a CD for later analysis. The cough airflow recordings will be displayed, stored, and analyzed using LabChart software for Windows.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Laryngeal function in cough | cough airflow measure, vocal tasks, true vocal fold movement, spirometry test, and maximum expiratory pressure (MEP) assessment will be performed in this group. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| cough airflow measure | Other | Participants will produce multiple voluntary coughs for cough airflow assessment. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Peak expiratory flow rate (PEFR) | Maximum flow rate in expiratory phase, expressed in liters per second (L/s) | baseline |
| True vocal fold maximum abduction angles in inspiratory phase | The TVF maximum abduction angles during cough inspiratory phase of cough will be expressed in degrees. | baseline |
| True vocal fold maximum abduction angles in expiratory phase | True vocal fold maximum abduction angles in expiratory phase of cough will be expressed in degrees. | baseline |
| True vocal fold maximum adduction angles in compression phase | True vocal fold maximum adduction angles in compression phase of cough will be expressed in degrees. | baseline |
| Peak expiratory flow rise time (PEFRT) | Time to reach peak expiratory flow rate expressed in seconds | baseline |
| Cough volume acceleration (CVA) | A ratio of peak expiratory flow rate and peak expiratory flow rise time expressed in L/s/s | baseline |
| Expiratory phase duration | Duration of expiratory phase of cough expressed in seconds | baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Peak expiratory flow | Maximum flow rate during forced exhalation expressed in L/s | baseline |
| Maximum expiratory pressure | Maximum expiratory pressure will be expressed in cmH2O. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
The participants will represent a population of patients with glottal insufficiency due to unilateral true vocal fold immobility.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Karen W Hegland, Ph.D. | University of Florida | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Florida ENT Clinic | Gainesville | Florida | 32610 | United States | ||
| University of Florida Speech and Hearing Center |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D014826 | Vocal Cord Paralysis |
| ID | Term |
|---|---|
| D007818 | Laryngeal Diseases |
| D012140 | Respiratory Tract Diseases |
| D010038 | Otorhinolaryngologic Diseases |
| D020421 | Vagus Nerve Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| vocal tasks | Other | The assessment of glottal closure will be performed during phonation tasks. |
|
|
| true vocal fold movement | Other | The true vocal fold (TVF) movement in cough will be observed and recorded during cough production. |
|
|
| spirometry test | Other | The lung function test will require the participant to perform deep inhalations and forceful exhalations into the flow head of the spirometer during spirometry test. |
|
|
| maximum expiratory pressure (MEP) | Other | The assessment of maximum expiratory pressure will require forceful exhalations into a mouthpiece of a manometer during maximum expiratory pressure (MEP) assessment. |
|
|
| baseline |
| Degree of glottal closure | The degree of glottal closure will be assessed during phonation using glottic closure rating scale 1-6, 1=complete closure, 6=incomplete closure all along the vocal folds (Södersten et al., 1990). | baseline |
| Forced vital capacity (FVC) | Maximum amount of air that can be exhaled with maximal speed and effort after maximum inhalation, expressed in L | baseline |
| Forced expired volume within 1 second (FEV1) | Maximum amount of air exhaled forcefully within 1 second, expressed in L. | baseline |
| The ratio FEV1/FVC | The percent (%) of forcefully exhaled air that can be exhaled during the first second of exhalation. | baseline |
| Gainesville |
| Florida |
| 32610 |
| United States |
| D003389 | Cranial Nerve Diseases |
| D009422 | Nervous System Diseases |
| D010243 | Paralysis |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |